First Financial Bank N.A. Trust Division increased its stake in Colgate-Palmolive Co. (NYSE:CL) by 1.2% during the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 35,200 shares of the company’s stock after buying an additional 406 shares during the period. First Financial Bank N.A. Trust Division’s holdings in Colgate-Palmolive were worth $2,610,000 at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in CL. Krilogy Financial LLC raised its position in shares of Colgate-Palmolive by 3.2% in the second quarter. Krilogy Financial LLC now owns 1,504 shares of the company’s stock worth $110,000 after buying an additional 46 shares in the last quarter. Tompkins Financial Corp raised its stake in Colgate-Palmolive by 121.1% in the second quarter. Tompkins Financial Corp now owns 1,698 shares of the company’s stock valued at $124,000 after buying an additional 930 shares during the period. Arcadia Investment Management Corp MI raised its stake in Colgate-Palmolive by 28.6% in the second quarter. Arcadia Investment Management Corp MI now owns 1,800 shares of the company’s stock valued at $132,000 after buying an additional 400 shares during the period. FCM Investments TX purchased a new stake in Colgate-Palmolive during the second quarter valued at $132,000. Finally, Orrstown Financial Services Inc. raised its stake in Colgate-Palmolive by 26.7% in the second quarter. Orrstown Financial Services Inc. now owns 2,280 shares of the company’s stock valued at $167,000 after buying an additional 480 shares during the period. Institutional investors and hedge funds own 71.73% of the company’s stock.

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Shares of Colgate-Palmolive Co. (NYSE:CL) traded up 0.15% during mid-day trading on Tuesday, hitting $66.53. The company had a trading volume of 2,674,141 shares. Colgate-Palmolive Co. has a 12-month low of $61.40 and a 12-month high of $75.38. The firm has a market cap of $59.13 billion, a PE ratio of 43.51 and a beta of 0.73. The firm’s 50 day moving average is $69.68 and its 200-day moving average is $72.19.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings results on Thursday, October 27th. The company reported $0.73 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.73. Colgate-Palmolive had a return on equity of 6,924.14% and a net margin of 8.96%. The company earned $3.87 billion during the quarter, compared to analysts’ expectations of $3.94 billion. During the same quarter in the previous year, the firm earned $0.80 earnings per share. The business’s quarterly revenue was down 3.3% compared to the same quarter last year. On average, equities analysts expect that Colgate-Palmolive Co. will post $2.82 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, November 15th. Investors of record on Monday, October 24th were given a dividend of $0.39 per share. The ex-dividend date of this dividend was Thursday, October 20th. This represents a $1.56 annualized dividend and a dividend yield of 2.34%. Colgate-Palmolive’s dividend payout ratio is presently 101.96%.

ILLEGAL ACTIVITY WARNING: “First Financial Bank N.A. Trust Division Increases Position in Colgate-Palmolive Co. (CL)” was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this story on another site, it was illegally stolen and reposted in violation of US & international copyright laws. The correct version of this story can be viewed at

CL has been the topic of a number of analyst reports. B. Riley reaffirmed a “neutral” rating and set a $71.00 price objective on shares of Colgate-Palmolive in a research note on Wednesday, August 3rd. KeyCorp initiated coverage on Colgate-Palmolive in a research report on Thursday, September 8th. They set a “sector weight” rating on the stock. Bank of America Corp. upgraded Colgate-Palmolive from a “neutral” rating to a “buy” rating and increased their target price for the stock from $70.86 to $80.00 in a research report on Monday, September 12th. Zacks Investment Research downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Tuesday, September 20th. Finally, Wells Fargo & Co. restated a “market perform” rating on shares of Colgate-Palmolive in a report on Tuesday, November 15th. Twelve analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average price target of $76.04.

In related news, insider Patricia Verduin sold 3,834 shares of the business’s stock in a transaction dated Monday, October 17th. The stock was sold at an average price of $72.39, for a total transaction of $277,543.26. Following the completion of the transaction, the insider now owns 55,013 shares of the company’s stock, valued at approximately $3,982,391.07. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 1.05% of the company’s stock.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company (Colgate) is a consumer products company, whose products are marketed in over 200 countries and territories throughout the world. The Company’s segments include Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through over five geographic segments, which include North America, Latin America, Europe/South Pacific, Asia and Africa/Eurasia.

5 Day Chart for NYSE:CL

Receive News & Stock Ratings for Colgate-Palmolive Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Co. and related stocks with our FREE daily email newsletter.